GoodRx Holdings Inc (GDRX) volume exceeds 1.92 million: A new investment opportunity for investors

On Tuesday, GoodRx Holdings Inc (NASDAQ: GDRX) was 1.56% up from the session before settling in for the closing price of $4.49. A 52-week range for GDRX has been $4.09 – $9.26.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 16.71%. When this article was written, the company’s average yearly earnings per share was at 13.47%. With a float of $88.69 million, this company’s outstanding shares have now reached $105.95 million.

Let’s determine the extent of company efficiency that accounts for 738 employees. In terms of profitability, gross margin is 89.76%, operating margin of 10.05%, and the pretax margin is 3.97%.

GoodRx Holdings Inc (GDRX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward GoodRx Holdings Inc stocks. The insider ownership of GoodRx Holdings Inc is 76.88%, while institutional ownership is 16.15%. The most recent insider transaction that took place on Dec 02 ’24, was worth 471,451. Before that another transaction happened on Sep 03 ’24, when Company’s 10% Owner sold 10,677 for $7.86, making the entire transaction worth $83,922. This insider now owns 0 shares in total.

GoodRx Holdings Inc (GDRX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.1 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 13.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.25% during the next five years compared to -17.73% drop over the previous five years of trading.

GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators

You can see what GoodRx Holdings Inc (GDRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21. Likewise, its price to free cash flow for the trailing twelve months is 9.58.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.47 in one year’s time.

Technical Analysis of GoodRx Holdings Inc (GDRX)

Looking closely at GoodRx Holdings Inc (NASDAQ: GDRX), its last 5-days average volume was 1.89 million, which is a jump from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 7.48%. Additionally, its Average True Range was 0.27.

During the past 100 days, GoodRx Holdings Inc’s (GDRX) raw stochastic average was set at 15.56%, which indicates a significant increase from 13.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.63% in the past 14 days, which was lower than the 57.37% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.72, while its 200-day Moving Average is $6.40. However, in the short run, GoodRx Holdings Inc’s stock first resistance to watch stands at $4.64. Second resistance stands at $4.71. The third major resistance level sits at $4.82. If the price goes on to break the first support level at $4.46, it is likely to go to the next support level at $4.35. Now, if the price goes above the second support level, the third support stands at $4.28.

GoodRx Holdings Inc (NASDAQ: GDRX) Key Stats

There are 383,610K outstanding shares of the company, which has a market capitalization of 1.75 billion. As of now, sales total 792,320 K while income totals 16,390 K. Its latest quarter income was 198,580 K while its last quarter net income were 6,740 K.